-
PROVIDERS
REGISTER NOW
Navigating new frontiers in breast cancer care pathway intelligence: The role of providers and AI
Tuesday, July 29th
2:00pm PT, 4:00pm CT, 5:00pm ET -
LIFE SCIENCES
REGISTER NOW
Closing Care Gaps with AI: The Next Competitive Edge in Pharma
Monday, July 14
9am PT, 11am CT, 12pm ET -
PATIENTS
It's About Time
View the Tempus vision.
- RESOURCES
-
ABOUT US
View Job Postings
We’re looking for people who can change the world.
- INVESTORS
Content
-
WebinarsIndustry Expert Theater Presentation* from the 2025 ASCO® Annual Meeting
Powering Today’s Insights for a Smarter Tomorrow: Intelligent Diagnostics and AI Solutions Across the Cancer Continuum -
WebinarsAlterations Drive Decisions: Advancing Personalized Care with Comprehensive Genomic Profiling
Part 2 of "Are you getting the full picture? A series on the power of comprehensive intelligent diagnostics." -
WebinarsOne Blood Sample, Many Options: The Benefits of Tumor + Normal Match
Part 1 of "Are you getting the full picture? A series on the power of comprehensive intelligent diagnostics." -
WebinarsScientific breakthroughs across the cancer continuum: Research from the 2024 ASCO® Annual Meeting
Join experts as they discuss innovative approaches to patient management in cancer care. Learn about new data from the 2024 ASCO® Annual Meeting, including Tempus' new MRD and monitoring portfolio, major lung cancer trial discoveries, and advancements in outcomes for advanced breast cancer. -
Webinars
Harnessing the power of AI: Optimizing workflows & enhancing testing across the cancer care continuum
Learn how AI is improving cancer care by making it more precise, tailored, and successful. Our newest tools, including One, Lens, Next, and Link, are making clinical and research work more efficient. Our move into MRD and monitoring uses these tools to better track patient progress and help healthcare and pharmaceutical partners monitor treatments. -
Case StudiesRevolutionizing Cardiac Care: AI-driven detection and treatment of critical heart valve disease at Boulder Community Health
Discover how Tempus Next's AI-powered care pathway platform transformed patient outcomes by helping ensure timely, guideline-directed treatment for critical heart valve disease at Boulder Community Health -
VideosTempus Presentation at the 2024 ASCO® Annual Meeting
Transforming Precision Medicine: AI and Molecular Insights Intersect Across the Cancer Care Continuum -
WebinarsLiquid biopsy’s role in biomarker-driven NSCLC Management
Discover how Dr. Wade Iams of Vanderbilt University is utilizing liquid biopsy as a valuable tool for broad biomarker detection and monitoring resistance mechanisms to therapeutic pressure in NSCLC. -
VideosIntroducing Tempus Next: Care Pathway Intelligence Solution
Chris Scotto DiVetta, SVP of Applications at Tempus AI introduces Tempus Next, an AI enabled care pathway platform that helps providers accelerate the adoption of evidence based care. -
Case StudiesIdentifying patients with Valvular Heart Disease: A partnership between St.Francis and Tempus
Learn how the deployment of Tempus Next, an AI-enabled clinical care pathway solution at St. Francis enabled guideline directed care for patients with structural heart disease. -
Case StudiesClosing the biomarker testing gap for early stage NSCLC patients with Tempus Next
Learn how Tempus Next was deployed at TriHealth Cancer and Blood Institute in Cincinnati, Ohio to surface and close gaps in biomarker testing for NSCLC patients. -
WebinarsLeveraging RNA sequencing to identify actionable biomarkers in NSCLC management
Join us in a dynamic discussion with Dr. Marc Matrana of Ochsner Health as he shares how RNA sequencing revealed new treatment options for his patient when DNA seq was unsuccessful identifying key, actionable biomarkers. -
VideosTempus Innovation Theater Presentation* from the 2023 RSNA Annual Meeting
Empowering Precision Medicine with Tempus Pixel -
VideosTempus Product Theater Presentation* from the 2023 San Antonio Breast Cancer Symposium
Integrating AI-Enabled Technology and Comprehensive Molecular Profiling to Enhance Breast Cancer Care -
Case StudiesPersonalized depression treatment with pharmacogenomic testing
This real-world case shows the impact of using the Tempus nP PGx report to inform treatment in major depressive disorder (MDD). -
Case StudiesTriHealth achieved 64% annual increase in patients enrolled in clinical trials, with Tempus TIME driving 95% of growth.
Discover how a multi-location hospital network leveraged TIME to dramatically increase clinical trial enrollment across their oncology portfolio. -
ArticlesQ&A: Grow your clinical trial portfolio and increase enrollment with the TIME clinical trial network
Jason Claes, Clinical Research Manager at TriHealth, shares his perspective on optimizing TIME to increase clinical trial enrollment. -
ArticlesFive key learnings from an evidence and guidelines-based application of PGx in mental health
Physicians discuss the role of pharmacogenomics in clinical practice. -
Webinars
Evidence & guidelines-based application of PGx in mental health
Learn how evidence and guidelines-based pharmacogenomics (PGx) can be a useful tool to inform medication selection and dosing in psychiatry. -
ArticlesQ&A: The evolution of RWE & HEOR—A conversation with two biopharmaceutical executives
Dr. Gupta and Dr. Iyer discuss the evolution of RWD in HEOR with Dr. Sasser.